Genesis HealthCare (GEN) Misses Q2 EPS by 27c

Genesis HealthCare (NYSE: GEN) reported Q2 EPS of ($0.26), $0.27 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.4 billion.

For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• Hermès can regain momentum despite China weakness, Jefferies says